| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2793.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, NY.
Correspondence to Bruce B. Lerman, MD, Division of Cardiology, Cornell University Medical Center, 525 East 68th St, Starr 409, New York, NY 10021. E-mail blerman{at}med.cornell.edu
Background We previously proposed that adenosine has mechanism-specific effects on atrial tachycardia (AT), such that adenosine terminates AT attributable to triggered activity, transiently suppresses automatic rhythms, and has no effect on macroreentrant AT. This, however, remains controversial, because other studies have reported that adenosine terminates reentrant AT. To clarify this issue, we used 3D electroanatomic mapping to delineate the tachycardia circuit and thereby determine whether the response to adenosine differentiates focal from macroreentrant AT.
Methods and Results We examined the effect of adenosine on 43 ATs in 42 consecutive patients (59±15 years of age; 26 female) who received adenosine during tachycardia and whose mechanism of AT was characterized by pharmacological perturbation, entrainment, 3D electroanatomic mapping, and results of radiofrequency ablation. Eight tachycardias were macroreentrant (noncavotricuspid isthmus-dependent), and 35 ATs were focal (either triggered or automatic). Adenosine administered during AT (at doses sufficient to result in AV block) terminated or transiently suppressed focal AT in 33 of 35 cases, whereas 8 of 8 macroreentrant ATs were adenosine insensitive (P<0.001). Twenty-eight of 35 focal ATs were located along the crista terminalis or tricuspid annulus.
Conclusions The response of AT to adenosine can immediately differentiate atrial tachycardia arising from a focal source from that attributable to macroreentry. This finding can be exploited to facilitate developing a focused, strategic ablative approach at the onset of a procedure.
Key Words: ablation adenosine tachycardia mapping
This article has been cited by other articles:
![]() |
C. Blomstrom-Lundqvist Drug treatment of supraventricular tachycardia Heart, November 1, 2009; 95(21): 1803 - 1807. [Full Text] [PDF] |
||||
![]() |
R. Weber, K. P. Letsas, T. Arentz, and D. Kalusche Adenosine sensitive focal atrial tachycardia originating from the non-coronary aortic cusp Europace, June 1, 2009; 11(6): 823 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.#x.;n. Farré, H. J.J. Wellens, J.#x. M. Rubio, and J. Benezet CHAPTER 28 Supraventricular Tachycardias ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Markowitz, D. Nemirovksy, K. M. Stein, S. Mittal, S. Iwai, B. K. Shah, D. P. Dobesh, and B. B. Lerman Adenosine-Insensitive Focal Atrial Tachycardia: Evidence for De Novo Micro-Re-Entry in the Human Atrium J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1324 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reising, F. Kusumoto, and N. Goldschlager Life-Threatening Arrhythmias in the Intensive Care Unit J Intensive Care Med, January 1, 2007; 22(1): 3 - 13. [Abstract] [PDF] |
||||
![]() |
N. Badhwar, J. M. Kalman, P. B. Sparks, P. M. Kistler, M. Attari, M. Berger, R. J. Lee, J. Sra, and M. M. Scheinman Atrial Tachycardia Arising From the Coronary Sinus Musculature: Electrophysiological Characteristics and Long-Term Outcomes of Radiofrequency Ablation J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1921 - 1930. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |